Related references
Note: Only part of the references are listed.Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
Jochen Kindler et al.
MOLECULAR PSYCHIATRY (2020)
Effects of inflammation on the kynurenine pathway in schizophrenia - a systematic review
Bruno Pedraz-Petrozzi et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia
Xingbing Huang et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)
Linking phencyclidine intoxication to the tryptophan-kynurenine pathway: Therapeutic implications for schizophrenia
Hidetsugu Fujigaki et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Modulation of Cerebellar Activity in Schizophrenia: Is It the Time for Clinical Trials?
Andrea Escelsior et al.
SCHIZOPHRENIA BULLETIN (2019)
L-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
Johanna Huttunen et al.
SCIENTIFIC REPORTS (2019)
Neuroinflammation in the dorsolateral prefrontal cortex in elderly chronic schizophrenia
Irene Lopez-Gonzalez et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Cerebellar-Prefrontal Network Connectivity and Negative Symptoms in Schizophrenia
Roscoe O. Brady et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Cytokine Alterations in Schizophrenia: An Updated Review
Sara Momtazmanesh et al.
FRONTIERS IN PSYCHIATRY (2019)
5-HIAA as a Potential Biological Marker for Neurological and Psychiatric Disorders
Hridya Jayamohanan et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate
Stephen M. Stahl
CNS SPECTRUMS (2018)
Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: L Check for Relevance for schizophrenia
Maximilian Tufvesson-Alm et al.
NEUROPHARMACOLOGY (2018)
Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling
Geoffroy Laumet et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia
Joshua Chiappelli et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Relevance of Alternative Routes of Kynurenic Acid Production in the Brain
L. A. Ramos-Chavez et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience
J. P. Kesby et al.
TRANSLATIONAL PSYCHIATRY (2018)
Abnormal gene and protein expression of inflammatory cytokines in the postmortem brain of schizophrenia patients
Ghanshyam N. Pandey et al.
SCHIZOPHRENIA RESEARCH (2018)
A systematic review of metabolite biomarkers of schizophrenia
Jennifer Davison et al.
SCHIZOPHRENIA RESEARCH (2018)
Downregulation of GNA13-ERK network in prefrontal cortex of schizophrenia brain identified by combined focused and targeted quantitative proteomics
Mio Hirayama-Kurogi et al.
JOURNAL OF PROTEOMICS (2017)
Analysis of human cerebrospinal fluid monoamines and their cofactors by HPLC
Marta Batllori et al.
NATURE PROTOCOLS (2017)
The kynurenine pathway and the brain: Challenges, controversies and promises
Robert Schwarcz et al.
NEUROPHARMACOLOGY (2017)
Differential regulation of the TLR4 signalling pathway in post-mortem prefrontal cortex and cerebellum in chronic schizophrenia: Relationship with SP transcription factors
Karina S. MacDowell et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity
Magdalena E. Kegel et al.
PSYCHIATRY RESEARCH (2017)
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Eric Plitman et al.
SCHIZOPHRENIA BULLETIN (2017)
A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder
C. M. Sellgren et al.
MOLECULAR PSYCHIATRY (2016)
Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge
Jennifer M. Parrott et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Biochemical Analyses of Cerebrospinal Fluid for the Diagnosis of Neurometabolic Conditions. What Can We Expect?
Marta Batllori et al.
SEMINARS IN PEDIATRIC NEUROLOGY (2016)
Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia
Kenya Watanabe et al.
PSYCHIATRY RESEARCH (2015)
Alternative kynurenic acid synthesis routes studied in the rat cerebellum
Tonali Blanco Ayala
Frontiers in Cellular Neuroscience (2015)
The SLC7A7 Transporter Identifies Microglial Precursors prior to Entry into the Brain
Federico Rossi et al.
CELL REPORTS (2015)
Kynurenine 3-monooxygenase: an influential mediator of neuropathology
Jennifer M. Parrott et al.
FRONTIERS IN PSYCHIATRY (2015)
Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis
B. R. E. Ansell et al.
PSYCHOLOGICAL MEDICINE (2015)
Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex
Sarah Beggiato et al.
NEUROPHARMACOLOGY (2014)
Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
Aye-Mu Myint et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Cerebellar-Thalamic Connectivity in Schizophrenia
Deanna M. Barch
SCHIZOPHRENIA BULLETIN (2014)
Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease
Amos A. Fatokun et al.
AMINO ACIDS (2013)
CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS
Andrew H. Miller et al.
DEPRESSION AND ANXIETY (2013)
Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: A pilot study of relationship to negative symptoms
Raquel Pinacho et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis
Patricia A. Zunszain et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
Daniel C. Javitt et al.
SCHIZOPHRENIA BULLETIN (2012)
Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
Korrapati V. Sathyasaikumar et al.
SCHIZOPHRENIA BULLETIN (2011)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia
J. K. Yao et al.
MOLECULAR PSYCHIATRY (2010)
Cortical Kynurenine Pathway Metabolism: A Novel Target for Cognitive Enhancement in Schizophrenia
Ikwunga Wonodi et al.
SCHIZOPHRENIA BULLETIN (2010)
Stability in schizophrenia symptoms over time: Findings from the Mount Sinai Pilgrim Psychiatric Center longitudinal study
A Reichenberg et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2005)
Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia
CL Miller et al.
NEUROBIOLOGY OF DISEASE (2004)
Cerebellar dysfunction in neuroleptic naive schizophrenia patients: Clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs
BC Ho et al.
BIOLOGICAL PSYCHIATRY (2004)
A gene-coexpression network for global discovery of conserved genetic modules
JM Stuart et al.
SCIENCE (2003)
Manipulation of brain kynurenines: Glial targets, neuronal effects, and clinical opportunities
R Schwarcz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Share Paper
